Wockhardt will deepen its novel antibiotics pipeline over the next five years and focus on building a biosimilar business for ...
17h
News-Medical.Net on MSNNew drug strategy targets Staphylococcus aureus toxin to treat pneumonia An International Res...Pneumonia caused by the bacterium Staphylococcus aureus is one of the most dangerous infections that can occur in hospital.
Meitheal Pharmaceuticals Announces Approval and Launch of Liraglutide Injection in the United States
Meitheal Pharmaceuticals, Inc. ("Meitheal"), a fully integrated biopharmaceutical company based in Chicago focused on the development and commercialization of generic injectables, fertility, biologic, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results